Synthetic biology-inspired therapies for metabolic diseases

Ana Palma Teixeira, Martin Fussenegger

Research output: Contribution to journalReview articlepeer-review

22 Citations (Scopus)


Our ability to engineer mammalian cells with effective therapeutic behaviors has brought new hope for treating metabolic diseases. Synthetic gene networks have been customized to interface with the host metabolism, discriminate between healthy and diseased states, and respond by producing an adjusted dose of the therapeutic molecule. Such devices have the potential to treat a range of dysfunctions that are simply not addressable using conventional therapies. Recently, the repurposing of native signaling pathways has formed the basis of autonomous therapeutic programs genetically installed in mammalian cells and has greatly expanded the possibilities to effectively tackle metabolic disorders. Here, we outline network topologies that have been successfully validated in animal models of metabolic diseases and discuss future developments that will be important for bringing this technology closer to clinical application.

Original languageEnglish
Pages (from-to)59-66
Number of pages8
JournalCurrent Opinion in Biotechnology
Publication statusPublished - 1 Oct 2017


Dive into the research topics of 'Synthetic biology-inspired therapies for metabolic diseases'. Together they form a unique fingerprint.

Cite this